Farzad Alemi

1.1k citations
15 papers · 814 indexed · h-index 9
Topics
Pancreatic and Hepatic Oncology Research (7 papers)Cholangiocarcinoma and Gallbladder Cancer Studies (4 papers)Neuroendocrine Tumor Research Advances (3 papers)

In The Last Decade

Farzad Alemi

15 papers receiving 796 citations

Peers

Farzad Alemi
Comparison fields: 5 of 74
  • Oncology 359
  • Surgery 341
  • Molecular Biology 215
  • Gastroenterology 152
  • Epidemiology 128
Replace Juneyoung Lee with:
Juneyoung Lee United States
Anita Balakrishnan United Kingdom
Rakesh Vinayek United States
Masatoshi Matsunami Japan
G. Willems Belgium
Hajime Nagase Japan
Naru Babaya Japan
Cemil Korcan Ayata Germany
A. P. Dick United Kingdom
Masayuki Sakiyama Japan
Farzad Alemi relative to Juneyoung Lee United States Juneyoung Lee's profile →
Citations per field
00.5×2.7×
Juneyoung Lee · 1×
Citations per year

Countries citing papers authored by Farzad Alemi

Since Specialization
Citations

This map shows the geographic impact of Farzad Alemi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Farzad Alemi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Farzad Alemi more than expected).

Fields of papers citing papers by Farzad Alemi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Farzad Alemi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Farzad Alemi. The network helps show where Farzad Alemi may publish in the future.

Co-authorship network of co-authors of Farzad Alemi

This figure shows the co-authorship network connecting the top 25 collaborators of Farzad Alemi. A scholar is included among the top collaborators of Farzad Alemi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Farzad Alemi. Farzad Alemi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
#WorkIndexed citations
1 1
2 57
3 13
4 1
5 31
6 3
7 7
8 1
9 71
10 300
11 279
12 29
13 1
14 8
15 12

About Farzad Alemi

Farzad Alemi is a scholar working on Gastroenterology, Oncology and Hepatology, having authored 15 papers that have together received 814 indexed citations. Recurring topics across this work include Pancreatic and Hepatic Oncology Research (7 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (4 papers) and Neuroendocrine Tumor Research Advances (3 papers). The work is most often cited by research in Gastroenterology (152 citations), Hepatology (126 citations) and Oncology (359 citations). Farzad Alemi has collaborated with scholars based in United States, Australia and United Kingdom. Frequent co-authors include Carlos U. Corvera, Daniel P. Poole, Nigel W. Bunnett, Kristina Schoonjans, Fiore Cattaruzza, Jonathan Chiu, John R. Grider, Graeme S. Cottrell, Edwin Kwon and Subhashini Ayloo. Their work appears in journals such as Journal of Biological Chemistry, Journal of Clinical Investigation and Gastroenterology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026